PD09-02 ANTI-ADENOVIRAL ANTIBODY LEVELS PREDICT NADOFARAGENE FIRADENOVEC RESPONSE IN BCG-UNRESPONSIVE NMIBC: RESULTS FROM A PHASE 3 TRIAL
- Resource Type
- Source
- Journal of Urology. 206
- Subject
business.industry law Urology Cancer research Recombinant DNA Medicine Antibody level business Gene Viral vector law.invention - Language
- ISSN
- 1527-3792
0022-5347